The mRNA vaccines for COVID-19, made by Pfizer/BioNTech and Moderna, are among the most powerful vaccines the world has ever seen. According to clinical trial data, they are more than 94% effective at preventing symptomatic ...
Jul 14, 2021
1
582
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), was generally well tolerated and prompted neutralizing antibody activity in healthy ...
Jul 15, 2020
0
314
A booster dose of the Pfizer–BioNTech vaccine (BNT162b2) against SARS-CoV-2 after an initial two doses of either the CoronaVac inactivated virus vaccine or Pfizer–BioNTech mRNA vaccine is shown to provide protection against ...
Jan 24, 2022
0
27
One of the pressing questions about COVID-19 remains: How long does immunity last? One key indicator of immunity is the presence of virus-specific antibodies. Previous studies have provided conflicting accounts about whether ...
Nov 3, 2020
1
80
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that people with chronic inflammatory diseases, such as rheumatoid arthritis (RA), who take immunosuppressive ...
Nov 2, 2021
0
47
Hospitalized COVID-19 patients are substantially more likely to harbor autoantibodies—antibodies directed at their own tissues or at substances their immune cells secrete into the blood—than people without COVID-19, according ...
Sep 14, 2021
0
670
The original vaccinations for COVID-19 induce potent antibodies that protect against SARS-CoV-2.
Feb 15, 2023
1
137
Inflammation and blood clotting seen in very severe cases of COVID-19 may be caused by the antibodies sent to fight the disease activating unnecessary platelet activity in the lungs.
Jul 28, 2021
0
870
The immune system develops a high-quality antibody response after three encounters with the coronavirus spike protein. These antibodies are also capable of neutralizing omicron efficiently. This applies to people who are ...
Feb 3, 2022
0
374
A COVID vaccine that provokes an immune response through white blood cells has showed promise in trials, according to research Tuesday that provides new hope for people with compromised immune systems.
Nov 23, 2021
0
120
